PROACT EU-Response

The overall aim of the PROACT EU-Response project is to prepare Europe for future diseases of epidemic or pandemic potential by strengthening and building upon existing networks of experts and civil society focused on clinical therapeutic platform trials within hospital inpatient settings across Europe.
This network will provide the capacity to pivot rapidly in the event of an outbreak to implement large, multi-country platform trials investigating drug efficacy and performance of diagnostic tools, with a strong patient and public involvement. The civil society and community at large are engaged in the planning of the trials as well as in designing specific activities concerning communication and information for the public about health threats and how to avoid disinformation, particularly during an epidemic or pandemic.
This project is led by ANRS-MIE, Inserm and Sorbonne University, as part of a consortium of 20 European countries and 23 partners, including many teams in biostatistics, clinical research and social sciences, as well as numerous associations and citizens' groups.
Population: adult | Intervention type: Interventional Study